The PHOENIX group wants to offer the best service and ensure the safety of the medicines that reach patients. The company has worked diligently on the implementation of the EU Falsified Medicines Directive across all its business areas to be fully compliant with the legislation in all markets. But it was challenging for them to fulfill the FMD requirements for wholesale and 3PL activities as well as track and trace products through serial numbers. A lean and efficient solution had to be found, which allows capturing the current status of medicines according to FMD.
Movilitas.Cloud proved to be the right answer. It is not only connected to the European Medicines Verification System (EMVS) and to all 32 National Medicine Verification Systems (NMVSs) in Europe but also acts as a connection between PHOENIX’s systems and the systems of partners. By providing real-time feedback on the status of a product pack, it allows the stakeholders to immediately trigger required actions and identify packs that caused issues.
This case study, which was originally posted in the GS1 Healthcare Reference Book, outlines PHOENIX's journey to becoming FMD compliant and gives insights into what requirements other supply chain stakeholders need to fulfill.
Originally published on GS1
